Nothing Special   »   [go: up one dir, main page]

FI104177B1 - Menetelmä terapeuttisesti käyttökelpoisten oligonukleotidien valmistamiseksi - Google Patents

Menetelmä terapeuttisesti käyttökelpoisten oligonukleotidien valmistamiseksi

Info

Publication number
FI104177B1
FI104177B1 FI913169A FI913169A FI104177B1 FI 104177 B1 FI104177 B1 FI 104177B1 FI 913169 A FI913169 A FI 913169A FI 913169 A FI913169 A FI 913169A FI 104177 B1 FI104177 B1 FI 104177B1
Authority
FI
Finland
Prior art keywords
preparation
therapeutically useful
useful oligonucleotides
oligonucleotides
therapeutically
Prior art date
Application number
FI913169A
Other languages
English (en)
Swedish (sv)
Other versions
FI913169A0 (fi
FI913169A (fi
FI104177B (fi
Inventor
Hannelore Roesch
Anja Froehlich
Jose Flavio Ramalho-Ortigao
Matthias Montenarh
Hartmut Seliger
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI913169A0 publication Critical patent/FI913169A0/fi
Publication of FI913169A publication Critical patent/FI913169A/fi
Application granted granted Critical
Publication of FI104177B1 publication Critical patent/FI104177B1/fi
Publication of FI104177B publication Critical patent/FI104177B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R15/00—Details of measuring arrangements of the types provided for in groups G01R17/00 - G01R29/00, G01R33/00 - G01R33/26 or G01R35/00
    • G01R15/14—Adaptations providing voltage or current isolation, e.g. for high-voltage or high-current networks
    • G01R15/18—Adaptations providing voltage or current isolation, e.g. for high-voltage or high-current networks using inductive devices, e.g. transformers
    • G01R15/186—Adaptations providing voltage or current isolation, e.g. for high-voltage or high-current networks using inductive devices, e.g. transformers using current transformers with a core consisting of two or more parts, e.g. clamp-on type

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Power Engineering (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Polyesters Or Polycarbonates (AREA)
FI913169A 1990-07-02 1991-06-28 Menetelmä terapeuttisesti käyttökelpoisten oligonukleotidien valmistamiseksi FI104177B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4021019 1990-07-02
DE4021019 1990-07-02

Publications (4)

Publication Number Publication Date
FI913169A0 FI913169A0 (fi) 1991-06-28
FI913169A FI913169A (fi) 1992-01-03
FI104177B1 true FI104177B1 (fi) 1999-11-30
FI104177B FI104177B (fi) 1999-11-30

Family

ID=6409497

Family Applications (1)

Application Number Title Priority Date Filing Date
FI913169A FI104177B (fi) 1990-07-02 1991-06-28 Menetelmä terapeuttisesti käyttökelpoisten oligonukleotidien valmistamiseksi

Country Status (22)

Country Link
US (1) US5750669A (fi)
EP (1) EP0464638B1 (fi)
JP (1) JP3186795B2 (fi)
KR (1) KR100200400B1 (fi)
AT (1) ATE151076T1 (fi)
AU (1) AU647143B2 (fi)
CA (1) CA2045891C (fi)
CZ (1) CZ285408B6 (fi)
DE (1) DE59108644D1 (fi)
DK (1) DK0464638T3 (fi)
ES (1) ES2099718T3 (fi)
FI (1) FI104177B (fi)
GR (1) GR3023432T3 (fi)
HU (1) HU215147B (fi)
IE (1) IE912309A1 (fi)
IL (1) IL98672A (fi)
NO (1) NO303018B1 (fi)
NZ (1) NZ238769A (fi)
PT (1) PT98169B (fi)
SK (1) SK279544B6 (fi)
TW (1) TW206232B (fi)
ZA (1) ZA915056B (fi)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223618A (en) * 1990-08-13 1993-06-29 Isis Pharmaceuticals, Inc. 4'-desmethyl nucleoside analog compounds
ATE151773T1 (de) 1992-09-24 1997-05-15 Hoechst Ag Oligoribonucleotid- und ribozym-analoga mit terminalen 3'-3'-bzw.5'-5'-verknüpfungen
HU9501974D0 (en) * 1993-03-31 1995-09-28 Sterling Winthrop Inc Oligonucleotides with amide linkages replacing phosphodiester linkages
US6015886A (en) * 1993-05-24 2000-01-18 Chemgenes Corporation Oligonucleotide phosphate esters
US6605708B1 (en) 1993-07-28 2003-08-12 Hybridon, Inc. Building blocks with carbamate internucleoside linkages and oligonucleotides derived therefrom
US5855911A (en) * 1995-08-29 1999-01-05 Board Of Regents, The University Of Texas System Liposomal phosphodiester, phosphorothioate, and P-ethoxy oligonucleotides
US5898031A (en) 1996-06-06 1999-04-27 Isis Pharmaceuticals, Inc. Oligoribonucleotides for cleaving RNA
US7812149B2 (en) 1996-06-06 2010-10-12 Isis Pharmaceuticals, Inc. 2′-Fluoro substituted oligomeric compounds and compositions for use in gene modulations
US9096636B2 (en) * 1996-06-06 2015-08-04 Isis Pharmaceuticals, Inc. Chimeric oligomeric compounds and their use in gene modulation
WO2005121370A2 (en) * 2004-06-03 2005-12-22 Isis Pharmaceuticals, Inc. Oligomeric compounds that facilitate risc loading
US7309692B1 (en) 1996-07-08 2007-12-18 Board Of Regents, The University Of Texas System Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to GRB2 or CRK1
US6977244B2 (en) * 1996-10-04 2005-12-20 Board Of Regents, The University Of Texas Systems Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotides
CN1060177C (zh) * 1997-06-28 2001-01-03 中国科学院上海生物化学研究所 3′－单磷酸化寡核苷酸
US7704962B1 (en) 1997-10-03 2010-04-27 Board Of Regents, The University Of Texas System Small oligonucleotides with anti-tumor activity
US7285288B1 (en) 1997-10-03 2007-10-23 Board Of Regents, The University Of Texas System Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotides
US6087112A (en) 1998-12-30 2000-07-11 Oligos Etc. Inc. Arrays with modified oligonucleotide and polynucleotide compositions
US20030180789A1 (en) * 1998-12-30 2003-09-25 Dale Roderic M.K. Arrays with modified oligonucleotide and polynucleotide compositions
DE19935756A1 (de) * 1999-07-27 2001-02-08 Mologen Forschungs Entwicklung Kovalent geschlossenes Nukleinsäuremolekül zur Immunstimulation
DE19935303A1 (de) 1999-07-28 2001-02-08 Aventis Pharma Gmbh Oligonukleotide zur Inhibierung der Expression von humanem eg5
US6271360B1 (en) 1999-08-27 2001-08-07 Valigen (Us), Inc. Single-stranded oligodeoxynucleotide mutational vectors
EP1702983A3 (en) 2000-04-13 2007-01-10 Medical University of South Carolina Tissue-specific and pathogen-specific toxic agents, ribozymes, DNAzymes and antisense oligonucleotides and methods of use thereof
WO2001096357A2 (en) * 2000-06-13 2001-12-20 Proligo Llc Universal solid supports for solid phase oligosynthesis and methods for their preparation and use
EP1322656B1 (en) * 2000-09-26 2008-01-16 Idera Pharmaceuticals, Inc. Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
GB0114007D0 (en) * 2001-06-08 2001-08-01 Isis Innovation Oilgonucleotides
US7070933B2 (en) * 2001-09-28 2006-07-04 Gen-Probe Incorporated Inversion probes
CA2471967A1 (en) * 2002-01-03 2003-07-31 Board Of Regents, The University Of Texas System Wt1 antisense oligos for the inhibition of breast cancer
CA2474709A1 (en) * 2002-02-04 2003-08-14 Biomira, Inc. Immunostimulatory, covalently lipidated oligonucleotides
EP2957568B1 (en) 2002-11-05 2016-12-21 Ionis Pharmaceuticals, Inc. Compositions comprising alternating 2'-modified nucleosides for use in gene modulation
AU2003287505A1 (en) 2002-11-05 2004-06-03 Isis Pharmaceuticals, Inc. Chimeric oligomeric compounds and their use in gene modulation
US8569474B2 (en) 2004-03-09 2013-10-29 Isis Pharmaceuticals, Inc. Double stranded constructs comprising one or more short strands hybridized to a longer strand
US8394947B2 (en) 2004-06-03 2013-03-12 Isis Pharmaceuticals, Inc. Positionally modified siRNA constructs
US7884086B2 (en) 2004-09-08 2011-02-08 Isis Pharmaceuticals, Inc. Conjugates for use in hepatocyte free uptake assays
CA2679750A1 (en) 2008-09-23 2010-03-23 Nexus Dx, Inc. Methods for detecting nucleic acids in a sample
EP2781523A1 (en) 2013-03-18 2014-09-24 Miltenyi Biotec GmbH Lipophilic oligonucleotide analogs
KR101323476B1 (ko) * 2013-06-12 2013-10-31 조선미 건물용 층간소음 방지재와 이를 이용한 층간소음 방지구조 및 그 시공 방법
LU92821B1 (en) 2015-09-09 2017-03-20 Mologen Ag Combination comprising immunostimulatory oligonucleotides
GB2542425A (en) 2015-09-21 2017-03-22 Mologen Ag Means for the treatment of HIV
US10266843B2 (en) * 2016-04-08 2019-04-23 Translate Bio, Inc. Multimeric coding nucleic acid and uses thereof
CN111050806A (zh) 2017-06-02 2020-04-21 波涛生命科学有限公司 寡核苷酸组合物及其使用方法
CN112105748B (zh) 2018-04-05 2023-08-04 清华大学 测序和生产核酸序列的方法
SG11202009877XA (en) * 2018-04-12 2020-11-27 Wave Life Sciences Ltd Oligonucleotide compositions and methods of use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4123610A (en) * 1977-03-09 1978-10-31 The United States Government Nucleic acid crosslinking agent and affinity inactivation of nucleic acids therewith
US4711955A (en) * 1981-04-17 1987-12-08 Yale University Modified nucleotides and methods of preparing and using same
FR2540122B1 (fr) * 1983-01-27 1985-11-29 Centre Nat Rech Scient Nouveaux composes comportant une sequence d'oligonucleotide liee a un agent d'intercalation, leur procede de synthese et leur application
DE3332068A1 (de) * 1983-09-06 1985-03-21 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von nukleosidalkyl-, aralkyl- und arylphosphoniten und -phosphonaten
US4795700A (en) * 1985-01-25 1989-01-03 California Institute Of Technology Nucleic acid probes and methods of using same
US5276019A (en) * 1987-03-25 1994-01-04 The United States Of America As Represented By The Department Of Health And Human Services Inhibitors for replication of retroviruses and for the expression of oncogene products
EP0406309A4 (en) * 1988-03-25 1992-08-19 The University Of Virginia Alumni Patents Foundation Oligonucleotide n-alkylphosphoramidates
AU5418290A (en) * 1989-03-31 1990-11-05 University Patents Inc. Polynucleotide phosphorodithioates as therapeutic agents for retroviral infections

Also Published As

Publication number Publication date
CA2045891A1 (en) 1992-01-03
CS201491A3 (en) 1992-01-15
EP0464638A3 (en) 1992-09-02
FI913169A0 (fi) 1991-06-28
AU7947591A (en) 1992-01-02
NZ238769A (en) 1993-11-25
HUT62010A (en) 1993-03-29
EP0464638B1 (de) 1997-04-02
DE59108644D1 (de) 1997-05-07
HU215147B (hu) 2000-03-28
JP3186795B2 (ja) 2001-07-11
ATE151076T1 (de) 1997-04-15
PT98169A (pt) 1993-09-30
NO912585D0 (no) 1991-07-01
IE912309A1 (en) 1992-01-15
JPH05222088A (ja) 1993-08-31
EP0464638A2 (de) 1992-01-08
ES2099718T3 (es) 1997-06-01
FI913169A (fi) 1992-01-03
PT98169B (pt) 1998-12-31
DK0464638T3 (da) 1997-10-13
KR920002625A (ko) 1992-02-28
TW206232B (fi) 1993-05-21
FI104177B (fi) 1999-11-30
SK279544B6 (sk) 1998-12-02
HU912215D0 (en) 1991-12-30
CA2045891C (en) 2003-07-22
US5750669A (en) 1998-05-12
IL98672A (en) 1995-12-08
NO303018B1 (no) 1998-05-18
CZ285408B6 (cs) 1999-08-11
NO912585L (no) 1992-01-03
ZA915056B (en) 1992-03-25
AU647143B2 (en) 1994-03-17
GR3023432T3 (en) 1997-08-29
IL98672A0 (en) 1992-07-15
KR100200400B1 (ko) 1999-06-15

Similar Documents

Publication Publication Date Title
FI104177B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten oligonukleotidien valmistamiseksi
DE3887625D1 (de) Verfahren zur Herstellung von 1,1,1-Trifluorodichlorethan und von 1,1,1,2-Tetrafluorchlorethan.
DE3889393D1 (de) Verfahren zur Herstellung von 2,2,6,6-Tetramethyl-4-piperidylaminen.
DE3853060D1 (de) Verfahren zur Herstellung von Oligonucleotiden.
DE59100830D1 (de) Verfahren zur Herstellung von 3-Aminomethyl-3,5,5,-trimethyl-cyclohexylamin.
PT87055A (pt) Process of genetic engineering for the preparation of molecular markers
FR2680507B1 (fr) Nouvelles naphtylethylurees et naphtylethylthiourees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
DE68908616D1 (de) Verfahren zur Herstellung von 1,1,1-Trifluor-2,2-dichlorethan.
DE3885366D1 (de) Verfahren zur Herstellung von Pyrrolo-(3,4-c)pyrrolen.
DE69131967D1 (de) Verfahren zur Herstellung von 1,1-Diarylprolinolen
FI880467A (fi) Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 3,4-dihydro-2H-bentsopyraanien valmistamiseksi
DE59105348D1 (de) Verfahren zur Herstellung von 1,4-Alkylendiaminen.
DE3885720D1 (de) Verfahren zur Herstellung von 4-Amino-1,2,4-triazol-5-onen.
DE3887212D1 (de) Verfahren zur Herstellung von Derivaten von 6,7-Diazyl-7-desacetylforskolin.
DE59106456D1 (de) Verfahren zur Herstellung von linearen 1,3-Diketonen.
DE59103040D1 (de) Verfahren zur Herstellung von symmetrischen 2,2'-Methylen-bis-benztriazolylphenolen.
DE59104221D1 (de) Verfahren zur Herstellung von 2,3,5-Trimethyl-p-benzochinon.
DE59106016D1 (de) Verfahren zur Herstellung von 2,3-Dihydrobenzofuranen.
DE59300178D1 (de) Verfahren zur Herstellung von 2,5-disubstituierten Pyridinen.
SE8403929L (sv) Rekombinant-dna-molekyl, transformerade mikroorganismer och forfarande for framstellning av penicillin v-amidas
DE69009651D1 (de) Verfahren zur Herstellung von 3,4-Dihydrocumarinderivaten.
ATE115139T1 (de) Verfahren zur herstellung von 2,4-diamino-6- piperidinyl-pyrimidin-3-n-oxid.
DE69214982D1 (de) Verfahren zur Herstellung von 2',3'-dideoxy-2',3'-didehydronukleosiden
DE69110377D1 (de) Verfahren zur Herstellung von 2,4-Dichlor-3-alkyl-6-nitrophenol.
FR2621586B1 (fr) Nouveaux derives de l'azapirodecane, leur procede de preparation et leur application comme medicaments

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: SANOFI-AVENTIS DEUTSCHLAND GMBH

Free format text: SANOFI-AVENTIS DEUTSCHLAND GMBH

MA Patent expired